Brain-Signal Feedback Training to Improve Balance and Walking in Parkinson's
Tests brain-signal feedback with imagined movement to improve balance and walking in Parkinson's disease.
Plain-language title generated from the registry record
Registry title: The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease
Key facts
- Where
- Taipei, TaiwanSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 85 years old?
Source: NCT05800470, who can take part
Where in Taiwan
- National Yang Ming Chiao Tung UniversityTaipei, TaiwanTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- National Yang Ming Chiao Tung University
- Trial code
- NCT05800470
- Record updated
- 7 August 2025
- Original description
A cross-sectional study (part 1) aims to investigate the influence of fatigue on the MI ability in PD compared to healthy controls. A randomized controlled trial (part 2) aims to compare the effect of fNIRS-based NFB-MI on balance and gait performance versus MI only in people with PD.Read full original descriptionShow less
The Novel Application of fNIRS-based Neurofeedback to Enhance Effects of Motor Imagery on Balance and Gait Performance in Individuals With Parkinson's Disease
A cross-sectional study (part 1) aims to investigate the influence of fatigue on the MI ability in PD compared to healthy controls. A randomized controlled trial (part 2) aims to compare the effect of fNIRS-based NFB-MI on balance and gait performance versus MI only in people with PD.
Inclusion: aged 40-85 y/o; diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage < 4; stable medical condition; capability of walking independently for 10 minutes, which is the time needed for imagery walking training in order to eliminate the possible influence of physical fatigue.
Exclusion: using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months; Part 2; using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months; cognitive impairment indicated by MMSE score < 24; history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation); diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression); cognitive impairment indicated by MMSE score < 24; history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation); diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression); motor imagery ability indicated by KVIQ score < 25; unable recognize 26 letters in the English alphabet.
Part 1; Additional Inclusion Criteria for PD:; diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage < 4; stable medical condition; capability of walking independently without walking devices.